Pulmonary sarcoidosis: Current concepts and controversies

Comprehensive Therapy

Volumn 23, Issue 3, 1997, Pages 197-210

  Lynch III, Joseph P ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BUDESONIDE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; GALLIUM 67; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PREDNISONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FIBEROPTIC BRONCHOSCOPY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERCALCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; LYMPHADENOPATHY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; THORAX RADIOGRAPHY; TREATMENT INDICATION;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG NEOPLASMS; MALE; PATIENT SELECTION; SARCOIDOSIS, PULMONARY;

EID: 0030992137     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Lynch JP III, Strieter RM. Sarcoidosis. In: Lynch JP III, DeRemee R, eds. Immunologically Mediated Pulmonary Disorders. J.B. Lippincott Co: Philadelphia, PA; 1991:189-216.
2. Sharma OP, Badr A. Sarcoidosis: diagnosis, staging, and newer diagnostic modalities. Clin Pulm Med. 1994:1;18-26.
3. Baughman RP, Lower EE, Lynch JP III. Treatment modalities for sarcoidosis. Clin Pulm Med. 1994:1;223-231.
4. Lynch JP III, Hunninghake GW. Sarcoidosis. In: Lichtenstein LM, Fauci AS, eds. Current Therapy in Allergy, Immunology, and Rheumatology. Philadelphia, PA: Mosby Year Book, B.C. Decker; 1992:243-251.
5. Sharma OP. Pulmonary sarcoidosis and corti-costeroids. Am Rev Respir Dis. 1993:147;1598-1600.
6. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis: a 15-year European study. Am Rev Respir Dis. 1984: 130;29-32.
7. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Quart J Med. 1983: 208;525-533.
8. Romer FK. Presentation of sarcoidosis and outcome of pulmonary changes: a review of 243 patients followed for up to 10 years. Dan Med Bull 1982:29;27-32.
9. Gideon NM, Mannino DM. Sarcoidosis mortality in the United States, 1979-1981: an analysis of multiple-cause mortality data. Am J Med. 1996:100;423-427.
10. Gibson GJ, Prescott RJ, Muers MF, Middleton WG, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax. 1996:51;238-247.
11. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med. 1994:149;893-898.
12. Chiles C, Putnam CE. Pulmonary sarcoidosis. Semin Respir Med. 1992:13;345-357.
13. Sieder L, Horton ES. Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography. J Thorac Imaging. 1990:5; 77-80.
14. Roberts CM, Citron KM, Strickland B. Intrathoracic aspergilloma: role of CT in diagnosis and treatment. Radiology. 1987:165;123-128.
15. Lynch JP III, Chavis AD. Chronic interstitial pulmonary disorders. In: Victor L, ed. Clinical Pulmonary Medicine. Boston, MA: Little Brown; 1992:193-264.
16. Winterbauer RH, N Belic, KD Moores. A clinical interpretation of bilateral hilar adenopathy. Ann Intern Med. 1973:78;65-71.
17. Brauner MW, Lenoir S, Grenier P, Cluzel P, Battesti JP, Valeyre D. Pulmonary sarcoidosis: CT assessment of reversibility. Radiology. 1992: 182;349-345.
18. Mana J, Tierstein AS, Mendelson DS, Padilla ML, DePalo LR. Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax. 1995:50;1264-1266.
19. Murdoch J, Muller NL. Pulmonary sarcoidosis: changes on follow-up CT examination. AJR. 1992:159;473-477.
20. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology. 1994:191;675-680.
21. Bradvik I, Wollmer P, Blom-Bulow B, Albrechtsson U, Jonson B. Lung mechanics and gas exchange during exercise in pulmonary sarcoidosis. Chest. 1991:99;572-578.
22. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest. 1995:107;323-329.
23. Sulavik SB, Spencer RP, Palestro CJ, Swyer AJ, Teirstein AS, Goldsmith SJ, Specificity and sensitivity of distinctive chest radiographic and/or Ga67 images in the noninvasive diagnosis of sarcoidosis. Chest 1993:103;403-409.
24. Winterbauer RH, Lemmert J, Selland M, et al. Bronchoalveolar lavage cell profiles in the diagnosis of sarcoidosis. Chest 1993:104;352-361.
25. Girgis RE, Basha MA, Maliarik M, Popovich J Jr, Iannuzzi MC. Cytokines in bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am J Respir Crit Care Med. 1996: 152;71-75.
26. Jones CM, Lake RA, Wijeyekoon JB, Mitchell DM, du Bois RM, O'Hehir RE. Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients. Am J Respir Cell Mol Biol. 1996:14;470-477.
27. Alberts C, van der Mark TW, Jansen HM. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study: Dutch Study Group on Pulmonary Sarcoidosis. Eur Respir J. 1995:8;682-688.
28. Lower EE, Baughman RP. Prolonged use of methotrexate in sarcoidosis. Arch Intern Med. 1995:155;846-851.
29. Yves M, Pinkston P, Saltini C, Spurzem J, Muller-Quernheim J, Crystal RG. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am Rev Respir Dis. 1988:138;1242-1248.
30. Martinez FJ, Orens JB, Deeb M, Brunsting LA, Flint A, Lynch JP III. Recurrence of sarcoidosis following allogeneic lung transplantation. Chest 1994:106;1597-1599.